US EditionDNA Demethylating Agents Suppress Preclinical Models of Synovial Sarcoma
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
DNA Demethylating Agents Suppress Preclinical Models of Synovial Sarcoma
Given that synovial sarcoma is characterized by a peculiarly low DNA hypomethylation profile, researchers hypothesized that further disturbance of DNA methylation would have a negative impact on synovial sarcoma growth. [Journal of Clinical Investigation] AbstractGraphical Abstract
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage